NLRP3 and Parkinson disease: Microglial-mediated neuroinflammation has been reported in many neurodegenerative disorders, and uncontrolled NLRP3 inflammasome activation in microglial cells has been observed in the tissue of the substantia nigra in the midbrain of patients with Parkinson’s disease[56, 60].